SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-027592
Filing Date
2024-03-07
Accepted
2024-03-07 08:03:10
Documents
14
Period of Report
2024-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rapt-20240307.htm   iXBRL 8-K 39654
2 EX-99.1 rapt-ex99_1.htm EX-99.1 158476
3 GRAPHIC img152904466_0.jpg GRAPHIC 3854
  Complete submission text file 0000950170-24-027592.txt   330293

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapt-20240307.xsd EX-101.SCH 25973
15 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20240307_htm.xml XML 4930
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 24728197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)